SCHEMBL25894

SCHEMBL25894

C1=Cc2ccccc2[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211354 0.82 TRPA1 (0.30)
SCHEMBL1245585 0.80 KDM4E (0.35)
Quinoline SCHEMBL1162952 0.74 TRPA1 (0.31)
Cinnoline SCHEMBL450150 0.74 TRPA1 (0.31)
SCHEMBL1395835 0.74 ALDH1A1 (0.36)
SCHEMBL206344 0.72 TRPA1 (0.34)
Quinoxaline SCHEMBL451431 0.72 ALDH1A1 (0.33)
SCHEMBL6843536 0.71 MAPT (0.39)
SCHEMBL612799 0.71 MAPT (0.39)
SCHEMBL9432585 0.71 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9433 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145659-A1 HETEROCYCLE FUSED GAMMA-CARBOLINES ACTING ON THE SEROTONINE 5-HT2A RECEPTOR INTRA-CELLULAR THERAPIES, INC. (US) 2024-07-04 WO claimed
CN-118253348-A Carbonylation catalyst, preparation method and application thereof 万华化学集团股份有限公司 2024-06-28 CN claimed
WO-2024112258-A1 SEROTONIN RECEPTOR AS A TARGET FOR THERAPY AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2024-05-30 WO claimed
EP-4361141-A1 PROTEIN DEGRADATION AGENT Suzhou Kintor Pharmaceuticals, Inc. (CN) 2024-05-01 EP claimed
CN-117940431-A Compound, light-emitting material, and light-emitting element 九州有机光材股份有限公司 2024-04-26 CN claimed
WO-2024074641-A1 METHOD FOR PREPARING AMIDES FROM ESTERS BASF SE (DE) 2024-04-11 WO claimed
US-20240059726-A1 GLYCOSYLATED HISTONE DEACETYLASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME GEORGIA TECH RESEARCH CORPORATION 2024-02-22 US claimed
CN-117545749-A Protein degradation agent 苏州开拓药业股份有限公司 2024-02-09 CN claimed
WO-2024027694-A1 PROTEIN DEGRADATION AGENT 苏州开拓药业股份有限公司 2024-02-08 WO claimed
CN-117466884-A Heterocyclic compounds or salts thereof as ATR kinase inhibitors, pharmaceutical compositions containing same and uses thereof 德州大学系统董事会 2024-01-30 CN claimed
EP-0039051-B1 MANNICH-BASE HYDROXAMIC ACID PRODRUGS FOR THE IMPROVED BIOAVAILABILITY OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM MERCK & CO. INC. (US) 1985-07-24 EP claimed
EP-0148128-A2 Optically active penem compounds CIBA-GEIGY AG (CH) 1985-07-10 EP claimed
US-4451462-A Method of treating inflammation and pain using heteramino benzofurans CIBA-GEIGY CORPORATION (US) 1984-05-29 US claimed
EP-0106800-A1 Furans CIBA-GEIGY AG (CH) 1984-04-25 EP claimed
US-4426380-A ANTIINFLAMMATORY, ANALGESIC, SUNSCREEN CIBA-GEIGY CORPORATION (US) 1984-01-17 US claimed
EP-0078241-A2 Furanes CIBA-GEIGY AG (CH) 1983-05-04 EP claimed
EP-0051278-A1 Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same MERCK & CO. INC. (US) 1982-05-12 EP claimed
EP-0039051-A2 Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them MERCK & CO. INC. (US) 1981-11-04 EP claimed
US-3957726-A S-TRIAZINE-IMIDE COPOLYMERS CIBA-GEIGY CORPORATION (US) 1976-05-18 US claimed
US-3946011-A S-Triazine tetracarboxylic acids and dianhydrides CIBA-GEIGY CORPORATION (US) 1976-03-23 US claimed